These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 33987343)
1. Inhibition of sphingosine kinase 2 down-regulates ERK/c-Myc pathway and reduces cell proliferation in human epithelial ovarian cancer. Dai L; Wang W; Liu Y; Song K; Di W Ann Transl Med; 2021 Apr; 9(8):645. PubMed ID: 33987343 [TBL] [Abstract][Full Text] [Related]
2. Activation of SphK2 contributes to adipocyte-induced EOC cell proliferation. Dai L; Wang C; Wang W; Song K; Ye T; Zhu J; Di W Open Med (Wars); 2022; 17(1):229-238. PubMed ID: 35178477 [TBL] [Abstract][Full Text] [Related]
3. Follicle-stimulating hormone promotes the proliferation of epithelial ovarian cancer cells by activating sphingosine kinase. Song K; Dai L; Long X; Wang W; Di W Sci Rep; 2020 Aug; 10(1):13834. PubMed ID: 32796926 [TBL] [Abstract][Full Text] [Related]
4. Sphingosine kinase 2 inhibitor ABC294640 displays anti-epithelial ovarian cancer activities in vitro and in vivo. Song K; Dai L; Long X; Cui X; Liu Y; Di W Onco Targets Ther; 2019; 12():4437-4449. PubMed ID: 31239712 [No Abstract] [Full Text] [Related]
5. MicroRNA-338-3p suppresses cell proliferation and induces apoptosis of non-small-cell lung cancer by targeting sphingosine kinase 2. Zhang G; Zheng H; Zhang G; Cheng R; Lu C; Guo Y; Zhao G Cancer Cell Int; 2017; 17():46. PubMed ID: 28428733 [TBL] [Abstract][Full Text] [Related]
6. Abnormal spindle-like microcephaly-associated protein promotes proliferation by regulating cell cycle in epithelial ovarian cancer. Wu Y; You Y; Chen L; Liu Y; Liu Y; Lou W; Fu F Gland Surg; 2022 Apr; 11(4):687-701. PubMed ID: 35531115 [TBL] [Abstract][Full Text] [Related]
7. LINC00968 accelerates the progression of epithelial ovarian cancer via mediating the cell cycle progression. Yao N; Sun JQ; Yu L; Ma L; Guo BQ Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4642-4649. PubMed ID: 31210289 [TBL] [Abstract][Full Text] [Related]
8. Down-regulation of long noncoding RNA DLX6-AS1 defines good prognosis and inhibits proliferation and metastasis in human epithelial ovarian cancer cells via Notch signaling pathway. Zhao J; Liu HR Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3243-3252. PubMed ID: 31081076 [TBL] [Abstract][Full Text] [Related]
9. Down-regulation of sphingosine kinase 2 (SphK2) increases the effects of all-trans-retinoic acid (ATRA) on colon cancer cells. Chu JH; Gao ZH; Qu XJ Biomed Pharmacother; 2014 Oct; 68(8):1089-97. PubMed ID: 25455157 [TBL] [Abstract][Full Text] [Related]
10. Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma. Zhang W; Niu C; He W; Hou T; Sun X; Xu L; Zhang Y Tumour Biol; 2016 May; 37(5):6239-54. PubMed ID: 26615423 [TBL] [Abstract][Full Text] [Related]
11. KCNMA1-AS1 attenuates apoptosis of epithelial ovarian cancer cells and serves as a risk factor for poor prognosis of epithelial ovarian cancer. Ma SY; Wei P; Qu F Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4629-4641. PubMed ID: 31210304 [TBL] [Abstract][Full Text] [Related]
12. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition. Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796 [TBL] [Abstract][Full Text] [Related]
13. β-hCG promotes epithelial ovarian cancer metastasis through ERK/MMP2 signaling pathway. Wu W; Gao H; Li X; Peng S; Yu J; Liu N; Zhan G; Zhu Y; Wang K; Guo X Cell Cycle; 2019 Jan; 18(1):46-59. PubMed ID: 30582718 [TBL] [Abstract][Full Text] [Related]
14. Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo. Zeng S; Liu S; Feng J; Gao J; Xue F Cancer Biomark; 2019; 24(4):421-428. PubMed ID: 30909184 [TBL] [Abstract][Full Text] [Related]
15. Circ-PGAM1 promotes malignant progression of epithelial ovarian cancer through regulation of the miR-542-3p/CDC5L/PEAK1 pathway. Zhang C; Li Y; Zhao W; Liu G; Yang Q Cancer Med; 2020 May; 9(10):3500-3521. PubMed ID: 32167655 [TBL] [Abstract][Full Text] [Related]
16. Significance of MNK1 in prognostic prediction and chemotherapy development of epithelial ovarian cancer. Hou S; Du P; Wang P; Wang C; Liu P; Liu H Clin Transl Oncol; 2017 Sep; 19(9):1107-1116. PubMed ID: 28332091 [TBL] [Abstract][Full Text] [Related]
17. SphK2/S1P Promotes Metastasis of Triple-Negative Breast Cancer Through the PAK1/LIMK1/Cofilin1 Signaling Pathway. Shi W; Ma D; Cao Y; Hu L; Liu S; Yan D; Zhang S; Zhang G; Wang Z; Wu J; Jiang C Front Mol Biosci; 2021; 8():598218. PubMed ID: 33968977 [TBL] [Abstract][Full Text] [Related]
18. KPNA2 promotes cell proliferation and tumorigenicity in epithelial ovarian carcinoma through upregulation of c-Myc and downregulation of FOXO3a. Huang L; Wang HY; Li JD; Wang JH; Zhou Y; Luo RZ; Yun JP; Zhang Y; Jia WH; Zheng M Cell Death Dis; 2013 Aug; 4(8):e745. PubMed ID: 23907459 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of sphingosine kinase 2 attenuates hypertrophic scar formation via upregulation of Smad7 in human hypertrophic scar fibroblasts. Zeng J; Jiang B; Xiao X; Zhang R Mol Med Rep; 2020 Sep; 22(3):2573-2582. PubMed ID: 32705254 [TBL] [Abstract][Full Text] [Related]
20. TRIP13 promotes proliferation and invasion of epithelial ovarian cancer cells through Notch signaling pathway. Zhou XY; Shu XM Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):522-529. PubMed ID: 30720159 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]